Osocimab clinical trials
Also written BAY1213790.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses osocimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses osocimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular HemodialysisCompletedPhase 2BayerNCT04523220Written as BAY1213790 (Osocimab)
- End-stage Renal Disease (ESRD) Pilot StudyCompletedPhase 1BayerNCT03787368Written as BAY1213790
- FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedPhase 2BayerNCT03276143Written as BAY1213790
Codes
What other systems call osocimab · ClinicalTrials.gg INT001260
- MeSH (NLM) C000657125osocimabOne source NLM
- UNII (FDA) EK5V9UL3WLOSOCIMABConfirmed FDA, NLM
- NCI Thesaurus C170268OsocimabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000657125 | osocimab | One source NLM |
| UNII (FDA) | EK5V9UL3WL | OSOCIMAB | Confirmed FDA, NLM |
| NCI Thesaurus | C170268 | Osocimab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.